Begin deliveries of ACAM2000 vaccine to the U.S. government
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 11 Sep 2025
- Due
- 30 Sep 2025
- Checked
- 1 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Deliveries are expected to begin this month.”
What we found
Evidence strength A What the grades mean
The company reported lower U.S. government ACAM2000 sales for the quarter ending September 30, 2025, citing timing issues, indicating the expected deliveries did not commence as planned.
-
A Emergent BioSolutions Inc. 10-Q filed 2025-10-30
“The decrease was primarily due to lower USG ACAM2000® and CNJ-016® (VIGIV) sales due to timing” ✓ confirmed on the page
Market reaction: the shares moved +12.2% against the S&P 500 over the three sessions around the disclosure (29 Oct 2025 to 3 Nov 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Production start
- Indicative materiality
- High rules
- Action
- Begin
- Deliverable
- ACAM2000 vaccine deliveries
- Where
- U.S.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Customer
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Emergent BioSolutions Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-EBS-002503 · Corrections policy